No Data
No Data
Ventyx Biosciences Reports Q3 Financial Results and Pipeline Progress
Ventyx Biosciences Analyst Ratings
Oppenheimer Maintains Ventyx Biosciences(VTYX.US) With Buy Rating, Cuts Target Price to $9
Ventyx Biosciences (VTYX) Receives a Buy From LifeSci Capital
Express News | Ventyx Biosciences : Oppenheimer Cuts Target Price to $9 From $10
Ventyx Biosciences Reports Q3 EPS (52c), Consensus ( 53c)
No Data
No Data